We are live on
!
Find out more
THP
Tower House Partners Portfolio holdings
AUM
$16.8M
1-Year Est. Return
41.98%
This Fund
S&P 500
This Quarter
Est. Return
+11.91%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$140M
AUM Growth
+$20.4M
(+17%)
Cap. Flow
+$6.42M
Cap. Flow
% of AUM
4.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ollie's Bargain Outlet
OLLI
|
+$9.5M |
| 2 |
Azenta
AZTA
|
+$6.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$9.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 74.42% |
| 2 | Consumer Staples | 25.58% |
Similar funds
RCGV
SCM
CCA
OHU
OA
JM
OP
AC
Tower House Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Tower House Partners held 3 positions worth $140M, up 17% from $120M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tower House Partners deployed $6.42M of net new capital in Q4 2019, adding to 2 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 80% a quarter earlier, followed by Consumer Staples.
On the sell side, the largest reduction was Bio-Rad Laboratories Class A, an estimated $9.39M trimmed.
- Tower House Partners added most to Ollie's Bargain Outlet in Q4 2019, an estimated $9.5M increase.
- Tower House Partners's biggest Q4 2019 reduction was Bio-Rad Laboratories Class A, cutting an estimated $9.39M.
- Tower House Partners's ten largest holdings make up 100% of its $140M portfolio in Q4 2019.
- Tower House Partners opened 0 new positions and closed 0 in Q4 2019.
- Tower House Partners's portfolio value rose 17% quarter-over-quarter to $140M.
Based on Tower House Partners's 13F filing for Q4 2019, filed 12 Feb 2020.